Survey of the Medical Digital Twin Market Status: Market Formation to Progress Gradually from Limited-Use DTs

Seed Planning Inc. (Headquarters: Bunkyo-ku, Tokyo; President: Yoshio Umeda) has conducted a survey on the medical digital twin (DT) market, analyzing its market formation structure, conditions for establishment, and promising areas.

Medical digital twins are gaining attention as a technology that reproduces patients, organs, diseases, and medical processes in a digital space to support diagnosis, treatment, research and development, and education. On the other hand, the definition and scope of medical digital twins are still fluid, and future concepts are mixed with technologies that are progressing towards implementation, making it difficult to evaluate the market as a whole.

In this survey, the medical digital twin market was organized into a three-layer structure of "Clinical Implementation," "Research & Development/Regulatory Compliance," and "Data Infrastructure/Ecosystem," along with an analysis of maturity by application, key players, conditions for market formation, and promising areas. As a result, we clarified the direction of future market formation by organizing not only technological trends but also conditions that influence market formation, such as data, validation/evaluation, regulations, workflows, and ROI.

●Details of the survey can be found here

https://www.seedplanning.co.jp/news/6402/

◆Background and Objectives of the Survey

Medical digital twins are attracting attention against the backdrop of advancements in AI, real-world data (RWD), medical DX, and in silico trials. However, their scope ranges widely from patient-specific models to whole-body digital twins, and their technological maturity and practical application stages vary, making it not easy to grasp the entire market correctly.

Furthermore, market formation involves various conditions beyond technology, such as clinical validation, regulatory compliance, compatibility with clinical workflows, data preparation, and cost-effectiveness (ROI).

This survey structurally organizes the medical digital twin market, clarifies areas where market formation is progressing and medium-to-long-term themes, and analyzes future market development and business opportunities.

◆Survey Topics

●Organized the medical digital twin market into a three-layer structure of clinical implementation, R&D/regulatory compliance, and data infrastructure.

●Analyzed the conditions for market establishment that influence marketization, such as data, validation/evaluation, regulations, workflows, and ROI.

●Analyzed promising areas and maturity levels where marketization is progressing.

●Future markets are expected to develop gradually from limited-use cases to disease-specific and integrated platforms.

◆Market Organization Status

【Market formation begins with limited-use DTs】

Medical digital twins are attracting attention against the backdrop of advancements in AI and simulation technologies, but the market as a whole is not taking off all at once. This survey organized the market into a three-layer structure of "Clinical Implementation Type," "R&D/Regulatory Compliance Type," and "Data Infrastructure/Ecosystem Type."

As a result, it was found that the most advanced in marketization currently are limited-use digital twins with clearly defined targets and applications, such as blood flow analysis and surgical planning in the cardiovascular field, medical device simulation, and in silico trials.

In this survey, we positioned medical digital twins with clear targets and applications as areas where market formation is leading.

On the other hand, while whole-body digital twins and Virtual Human Twins (VHTs) are expected to have future potential, they are currently in the research and infrastructure development stages.

【The key to market expansion is not just technology】

The medical digital twin market is not a market that grows solely on technological prowess. This analysis revealed that multifaceted factors such as differences in market definition, maturity levels in each implementation area, consistency with regulations and systems, cost-effectiveness, data infrastructure, and ecosystem formation significantly influence market formation.

It indicates that it is difficult to grasp the reality of the market solely by market size and growth rate, and it is necessary to evaluate the progress of market formation from multiple perspectives, including the number of adopting facilities, regulatory approvals, number of papers, and consortium formation.

【Organizing Leading and Future Markets】

In the medical digital twin market, not all areas will be commercialized at the same speed. This survey organized the market maturity of each area based on ease of data acquisition, ease of modeling, verifiability, and connectivity to clinical decision-making.

While commercialization is progressing in areas such as cardiovascular, surgical planning, blood flow analysis, and medical device simulation, areas like Oncology DT, ICU, and neurology are transitioning from research/demonstration to initial implementation. Furthermore, whole-body digital twins and VHTs are positioned as areas where long-term market formation is expected.

【Business opportunities change in the short, medium, and long term】

Business opportunities in the medical digital twin market are expected to change significantly in the short, medium, and long term. In the short term, limited-use digital twins such as cardiovascular and surgical planning are expected to lead the market. In the medium term, it will expand to disease-specific and application-specific digital twins, and in the long term, it is expected to develop into integrated digital twins linked with medical data infrastructure and ecosystems.

Therefore, business opportunities are expected to expand at different times for medical institutions, pharmaceutical/CRO companies, medical device manufacturers, and IT/data infrastructure providers, and strategic design based on one's own strengths and market maturity is important for market entry.

◆Survey Overview

Target of the survey:

- Research papers related to medical digital twins and related fields (virtual patient, in silico patient, patient-specific model, etc.) that have patient individualization and model/simulation functions.

- Corporate cases and implementation examples of digital twins in medical devices, diagnosis/treatment support, surgical planning, and R&D (in silico trials, etc.).

Survey method:

- Literature survey (collection and analysis of papers mainly collected using academic databases such as PubMed)

- Public information survey (collection and organization of gray literature such as corporate cases and industry reports)

- Expert interviews (interviews with specialists regarding medical digital twins, simulation in the cardiovascular field, clinical application, R&D/implementation challenges, etc.)

- Interview survey using face-to-face or web (in-depth interviews)

Survey items:

- Market definition of medical digital twins / Analysis of research and technological trends / Clinical implementation type DT and major players / Key companies and implementation examples of R&D/regulatory compliance type DT, etc.

Survey period:

March 2026 - June 2026

Inquiries about the materials:

Public Relations Department

E-mail : [email protected]